Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Lordick

Showing results (1-10 of 365) with videos related to

Pageof 37
Sort By:
Nature Reviews. Clinical Oncology|November 19, 2014
Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesisFlorian Lordick
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Salvage chemotherapy for advanced gastric cancer: more than a false hope?Florian Lordick
Future Oncology (London, England)|February 25, 2011
Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancerFlorian Lordick
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 28, 2012
To resect or not resect in metastatic gastric cancer: that is the question!Florian Lordick
The Lancet. Gastroenterology & Hepatology|October 29, 2017
Changing paradigms in adjuvant treatment of colorectal cancerFlorian Lordick
European Journal of Cancer (Oxford, England : 1990)|September 26, 2017
Treatment of oesophageal cancer - Stressing the patient perspectiveFlorian Lordick
The Lancet. Oncology|June 27, 2014
Targeting the HGF/MET pathway in gastric cancerFlorian Lordick
Oncology Research and Treatment|July 14, 2015
[New angiogenesis inhibitor Ramucirumab: longer survival and better symptom control]Florian Lordick
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Current standard and trends in oesophageal cancerFlorian Lordick
Acta Gastro-Enterologica Belgica|February 11, 2012
The role of PET in predicting response to chemotherapy in oesophago-gastric cancerFlorian Lordick
Pageof 37

Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Nature Reviews. Clinical Oncology|November 19, 2014
Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesisFlorian Lordick
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Salvage chemotherapy for advanced gastric cancer: more than a false hope?Florian Lordick
Future Oncology (London, England)|February 25, 2011
Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancerFlorian Lordick
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 28, 2012
To resect or not resect in metastatic gastric cancer: that is the question!Florian Lordick
The Lancet. Gastroenterology & Hepatology|October 29, 2017
Changing paradigms in adjuvant treatment of colorectal cancerFlorian Lordick
European Journal of Cancer (Oxford, England : 1990)|September 26, 2017
Treatment of oesophageal cancer - Stressing the patient perspectiveFlorian Lordick
The Lancet. Oncology|June 27, 2014
Targeting the HGF/MET pathway in gastric cancerFlorian Lordick
Oncology Research and Treatment|July 14, 2015
[New angiogenesis inhibitor Ramucirumab: longer survival and better symptom control]Florian Lordick
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Current standard and trends in oesophageal cancerFlorian Lordick
Acta Gastro-Enterologica Belgica|February 11, 2012
The role of PET in predicting response to chemotherapy in oesophago-gastric cancerFlorian Lordick
Pageof 37